We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$5.61B
AUM Growth
-$215M
Cap. Flow
-$399M
Cap. Flow %
-7.11%
Top 10 Hldgs %
40.7%
Holding
360
New
57
Increased
84
Reduced
99
Closed
57

Top Buys

Rank Stock Value
1
WHR icon
Whirlpool
WHR
+$117M
2
GE icon
GE Aerospace
GE
+$90.3M
3
M icon
Macy's
M
+$76.1M
4
HPE icon
Hewlett Packard
HPE
+$75.5M
5
HES
Hess
HES
+$69.2M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$102M
2
CI icon
Cigna
CI
+$88M
3
TGT icon
Target
TGT
+$84.9M
4
KKR icon
KKR & Co
KKR
+$57.2M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$48.8M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Technology 16.82%
3 Healthcare 10.88%
4 Materials 10.41%
5 Industrials 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIOA.WS
301
DELISTED
BioAmber Inc.
BIOA.WS
$10K ﹤0.01%
239,854
-30,162
-11% -$8.76K
ETP
302
DELISTED
Energy Transfer Partners L.p.
ETP
$5K ﹤0.01%
+10,000
New +$372K
AAP icon
303
Advance Auto Parts
AAP
$2.62B
– –
-1,292
Closed -$219K
ALB icon
304
Albemarle
ALB
$13.4B
– –
-83,582
Closed -$7.2M
ALE
305
DELISTED
Allete
ALE
– –
-3,939
Closed -$253K
AMG icon
306
Affiliated Managers Group
AMG
$9B
– –
-5,122
Closed -$744K
AMRC icon
307
Ameresco
AMRC
$1.19B
– –
-391,397
Closed -$2.15M
BALL icon
308
Ball Corp
BALL
$16.1B
– –
-15,000
Closed -$563K
BIO icon
309
Bio-Rad Laboratories Class A
BIO
$10.1B
– –
-267,619
Closed -$48.8M
BWXT icon
310
BWX Technologies
BWXT
$13.4B
– –
-9,500
Closed -$377K
CBRE icon
311
CBRE Group
CBRE
$40.6B
– –
-8,513
Closed -$268K
CHH icon
312
Choice Hotels
CHH
$4.38B
– –
-4,090
Closed -$229K
CMA
313
DELISTED
Comerica
CMA
– –
-3,392
Closed -$231K
CVX icon
314
Chevron
CVX
$427B
– –
-326,816
Closed -$38.5M
CWEN icon
315
Clearway Energy Class C
CWEN
$6.14B
– –
-1,784,942
Closed -$28.2M
DG icon
316
Dollar General
DG
$27.5B
– –
-2,997
Closed -$222K
GILD icon
317
Gilead Sciences
GILD
$181B
– –
-3,148
Closed -$225K
HCA icon
318
HCA Healthcare
HCA
$91.8B
– –
-10,500
Closed -$777K
HPQ icon
319
HP
HPQ
$30.5B
– –
-74,628
Closed -$1.11M
HUBB icon
320
Hubbell
HUBB
$23.2B
– –
-3,254
Closed -$380K
IRS
321
IRSA Inversiones y Representaciones
IRS
$1.3B
– –
-15,348
Closed -$273K
LW icon
322
Lamb Weston
LW
$6.47B
– –
-15,176
Closed -$574K
MDLZ icon
323
Mondelez International
MDLZ
$79.3B
– –
-40,159
Closed -$1.78M
NEE icon
324
NextEra Energy
NEE
$169B
– –
-745,440
Closed -$22.3M
ON icon
325
ON Semiconductor
ON
$28.5B
– –
-12,500
Closed -$159K
11 12
13
14 15

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return

Levin Capital Strategies's Q1 2017 Portfolio in Review

As of Q1 2017, Levin Capital Strategies held 360 positions worth $5.61B, down 3.7% from $5.82B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Levin Capital Strategies withdrew a net $399M in Q1 2017, closing 57 positions and reducing 99 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Whirlpool worth $113M.

  • Levin Capital Strategies's largest Q1 2017 buy was Whirlpool: 660,286 shares worth $113M.
  • Levin Capital Strategies added most to GE Aerospace in Q1 2017, an estimated $90.3M increase.
  • Levin Capital Strategies's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $102M.
  • Levin Capital Strategies fully exited Bio-Rad Laboratories Class A in Q1 2017, selling an estimated $48.8M.
  • Levin Capital Strategies's ten largest holdings make up 41% of its $5.61B portfolio in Q1 2017.
  • Levin Capital Strategies opened 57 new positions and closed 57 in Q1 2017.
  • Levin Capital Strategies's portfolio value fell 3.7% quarter-over-quarter to $5.61B.

Based on Levin Capital Strategies's 13F filing for Q1 2017, filed 9 May 2017.